Tuesday, March 17, 2026

Will Novo Nordisk’s 50% Price Cut on Wegovy Spark a Price War in Korea’s Obesity Drug Market?

Novo Nordisk's price cuts for GLP-1 obesity treatments in the U.S. may influence South Korean market dynamics, though immediate effects seem limited.

Nvidia Lost Half Its China Market—Now It’s Paying the Price

Nvidia CEO Jensen Huang criticized U.S. export controls on H20 chips to China, citing revenue losses and market share decline.

Moral SHAME: Lee Administration Sacrifices Human Life and Dignity Just To Appease A Tyrannical Regime

North Korean rights groups urge South Korea to co-sponsor a UN resolution, expressing concern over human rights under President Lee Jae Myung.

Tag: GERD

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

HK inno.N’s New Drug K-CAB Applies for U.S. FDA Approval: How Innovative Is the P-CAB Therapy?

HK inno.N's K-Cap for GERD has entered the U.S. approval process, showing superior results in clinical trials over existing treatments.

From R&D to Global Blockbuster: Fexuclue Sparks a New Vision for Daewoong

Daewoong Pharmaceutical's Fexuclue achieves rapid success with innovative marketing and aims for significant growth in treating GERD.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.